Skip to main content

Personalized therapy with TNF-inhibitors in Crohn’s disease: Optimizing treatment outcomes by moni-toring drug levels and anti-drug antibodies

Casper Steenholdt

1. aug. 2016
1 min.

Article opens in PDF